Bluberries
- Shares of Cogent Biosciences (COGT) are down ~5% in after-hours trading Tuesday following the disclosure that several insiders recently made significant sales.
- The company’s CFO, chief medical officer, chief science officer, and chief legal officer all disclosed sales in SEC filings.
